Original Article
Whole body PET-CT: M staging in non small- cell lung cancer
Author:
FX Hanin
Nuclear Medicine Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, BE
Abstract
FDG PET has been used for years in the diagnosis and recurrence of non small cell lung cancer (NSCLC). It has an important impact on patient management, and its coupling with CT for immediate fusion allows immediate localization and characterization of uptake. This article reviews the role of FDG PET-CT in the staging of NSCLC for the detection of metastatic disease.
How to Cite:
Hanin F. Whole body PET-CT: M staging in non small- cell lung cancer. Journal of the Belgian Society of Radiology. 2013;96(3):127–31. DOI: http://doi.org/10.5334/jbr-btr.233
Published on
01 May 2013.
Peer Reviewed
Downloads
